We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$859M
AUM Growth
-$429M
Cap. Flow
-$442M
Cap. Flow %
-51.43%
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$5.95M
2
MRVL icon
Marvell Technology
MRVL
+$4M
3
AAPL icon
Apple
AAPL
+$3.97M
4
DIS icon
Walt Disney
DIS
+$3.95M
5
ROL icon
Rollins
ROL
+$3.82M

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.11M
2
ICE icon
Intercontinental Exchange
ICE
+$6.91M
3
XRAY icon
Dentsply Sirona
XRAY
+$6.81M
4
CSCO icon
Cisco
CSCO
+$6.77M
5
QRVO icon
Qorvo
QRVO
+$6.72M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 16.59%
3 Industrials 13.62%
4 Financials 13.07%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRR
901
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$32.8K ﹤0.01%
32,803
– –
CDZI icon
902
Cadiz
CDZI
$260M
$32.1K ﹤0.01%
12,838
-4,129
-24% -$8.6K
INSG icon
903
Inseego
INSG
$120M
$31K ﹤0.01%
3,677
– –
HOOK
904
DELISTED
HOOKIPA Pharma
HOOK
$30.8K ﹤0.01%
3,799
– –
ATAI icon
905
AtaiBeckley Inc
ATAI
$2.66B
$30.4K ﹤0.01%
11,415
-97,051
-89% -$295K
QMCO icon
906
Quantum Corp
QMCO
$416M
$29.7K ﹤0.01%
1,364
-1,177
-46% -$28.9K
PRTK
907
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$29.4K ﹤0.01%
15,722
-31,442
-67% -$78.4K
AAOI icon
908
Applied Optoelectronics
AAOI
$10.6B
$28.8K ﹤0.01%
15,249
-1,150
-7% -$2.73K
CVM icon
909
CEL-SCI Corp
CVM
$21.8M
$26.2K ﹤0.01%
371
-464
-56% -$40.8K
ONCT
910
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$25.6K ﹤0.01%
1,281
-75
-6% -$1.49K
OPAD icon
911
Offerpad Solutions
OPAD
$17.3M
$24.4K ﹤0.01%
353
-168
-32% -$19.4K
TALK icon
912
Talkspace
TALK
$873M
$23.4K ﹤0.01%
38,288
-22,027
-37% -$16.9K
VIRX
913
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$18.8K ﹤0.01%
12,874
-10
-0.1% -$29
SRAX
914
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$11.7K ﹤0.01%
65,537
– –
TIL icon
915
Instil Bio
TIL
$49M
$11K ﹤0.01%
+871
New +$43K
PDYN icon
916
Palladyne AI
PDYN
$283M
$10.7K ﹤0.01%
+3,189
New +$27.2K
CNVS icon
917
Cineverse
CNVS
$58.5M
$7.77K ﹤0.01%
1,002
-9,355
-90% -$89.1K
ABCB icon
918
Ameris Bancorp
ABCB
$5.92B
– –
-5,390
Closed -$241K
ABCL icon
919
AbCellera Biologics
ABCL
$1.86B
– –
-162,885
Closed -$1.61M
ABUS icon
920
Arbutus Biopharma
ABUS
$861M
– –
-42,548
Closed -$81K
ACA icon
921
Arcosa
ACA
$7.14B
– –
-19,954
Closed -$1.14M
ACGL icon
922
Arch Capital
ACGL
$34.5B
– –
-36,589
Closed -$1.67M
ACN icon
923
Accenture
ACN
$101B
– –
-21,646
Closed -$5.57M
ACTG icon
924
Acacia Research
ACTG
$447M
– –
-12,605
Closed -$51K
ADM icon
925
Archer Daniels Midland
ADM
$37.6B
– –
-4,230
Closed -$340K
35 36
37
38 39

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Occudo Quantitative Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.

  • Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
  • Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
  • Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
  • Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
  • Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
  • Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.